| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8239890 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 7 Pages |
Abstract
A high level of disease control combined with favorable toxicity profiles was achieved in a cohort of HNC patients receiving PET/CT fusion guided radiotherapy plus/minus chemotherapy. Maximum SUV of primary tumor and/or adenopathy was not predictive of risk of disease recurrence.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Matthew R. B.S., Mohit M.D., Christopher J. M.D., Michelle A. M.D., Stuart J. M.D., Bruce H. M.D., Becky L. M.D., J. Frank M.D., Dian M.D., Ph.D.,